Scrutiny continues to hover around the relationship between medical marijuana and Texas. Back in 2015 Texas approved the Compassionate Use Act, which authorized the usage of CBD oil to patients with intractable epilepsy who have not responded to two types of federally approved medication.
It is one of the most limiting medical marijuana programs in the country. Though it was announced that Texans would see the opening of one of only three licensed dispensaries by late 2017, that date has been pushed back to early 2018.
Many families have left out by the program. None of the three licensed dispensaries reside either in the west half of the state nor along the Mexico-US border where townships are booming. In addition, because of the specificity of the law, it can exclude some patients who appear to qualify or who would seem to clearly benefit from the medication. As the Texas Observer notes, more than 345,000 Texans with epilepsy do not qualify under the Compassionate Use Act.
Among those patients is 12-year-old Micah Jensen, who has autism and temporal lobe epilepsy. Last year, he began suffering from severe migraines. Doctors determined that Micah’s frequent seizures were triggering inflammation and swelling in his brain, inducing the migraines, and that his body wasn’t responding properly to his anticonvulsant, Lamictal. Doctors upped his dosage of the powerful drug, which includes deleterious side effects like weight gain and can cause autistic behaviors to flare up such as self-injury.
Jensen’s [mother] started reading